Mepolizumab News
Mepolizumab currently has 0 news articles, with 20 predicted indications.
This page combines the AI-predicted indications for Mepolizumab with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Original indication: Severe eosinophilic asthmaNucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older . Chronic rhinosinusitis with...
- Evidence level: L5
- Predicted indications (20):
- thrombocytopenia due to immune destruction (99.7%)
- primary release disorder of platelets (99.6%)
- pseudo-von Willebrand disease (99.4%)
- autoimmune thrombocytopenic (99.3%)
- Glanzmann thrombasthenia (99.3%)
- Evans syndrome (98.6%)
- neonatal thrombocytopenia (98.6%)
- autosomal thrombocytopenia with normal platelets (98.4%)
- filariasis (97.7%)
- mixed-type autoimmune hemolytic anemia (96.6%)
- drug-induced autoimmune hemolytic anemia (96.4%)
- cyclic hematopoiesis (96.3%)
- proteinuria (95.9%)
- syndromic constitutional thrombocytopenia (95.9%)
- neonatal autoimmune hemolytic anemia (95.8%)
- paroxysmal nocturnal hemoglobinuria (95.5%)
- fetal and neonatal alloimmune thrombocytopenia (95.3%)
- hemorrhagic disorder due to a constitutional thrombocytopenia (94.6%)
- bleeding diathesis due to a collagen receptor defect (94.4%)
- Scott syndrome (94.4%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.